Patents by Inventor Mikael Søndergaard Thomsen

Mikael Søndergaard Thomsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11975104
    Abstract: Provided herewith is a pharmaceutical composition comprising, separately or together, a pulsatile release component comprising levodopa and a DOPA decarboxylase inhibitor for the management of OFF-time episodes in patients with Parkinson's disease.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: May 7, 2024
    Assignee: Contera Pharma A/S
    Inventors: John Bondo Hansen, Mikael Søndergård Thomsen, Ann Vivian Fullerton, Bent Højgaard, Peter Gudmund Nielsen
  • Patent number: 11819482
    Abstract: Provided is a pharmaceutical composition comprising suplatast tosilate or pharmaceutically acceptable derivatives thereof that provides for a constant exposure of the compound.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: November 21, 2023
    Assignees: Conrig Pharma ApS, Solural Pharma ApS
    Inventors: John Bondo Hansen, Mikael Søndergård Thomsen, Bent Højgaard
  • Publication number: 20230078925
    Abstract: Provided herewith is a pharmaceutical composition comprising, separately or together, a pulsatile release component comprising levodopa and a DOPA decarboxylase inhibitor for the management of OFF-time episodes in patients with Parkinson's disease.
    Type: Application
    Filed: September 7, 2022
    Publication date: March 16, 2023
    Inventors: John Bondo HANSEN, Mikael Søndergård THOMSEN, Ann FULLERTON, Bent HØJGAARD, Peter Gudmund NIELSEN
  • Publication number: 20200230083
    Abstract: Provided is a pharmaceutical composition comprising suplatast tosilate or pharmaceutically acceptable derivatives thereof that provides for a constant exposure of the compound.
    Type: Application
    Filed: August 28, 2018
    Publication date: July 23, 2020
    Inventors: John Bondo Hansen, Mikael Søndergård Thomsen, Bent Højgaard
  • Publication number: 20190290587
    Abstract: Provided herewith is a pharmaceutical composition comprising, separately or together, a pulsatile release component comprising levodopa and a DOPA decarboxylase inhibitor for the management of OFF-time episodes in patients with Parkinson's disease.
    Type: Application
    Filed: July 11, 2017
    Publication date: September 26, 2019
    Inventors: John Bondo Hansen, Mikael Søndergård Thomsen, Ann Vivian Fullerton, Bent Højgaard, Peter Gudmund Nielsen
  • Publication number: 20130303497
    Abstract: The present invention relates to new deuterated derivatives of serotonin 5-HT1A receptor agonists of formula 1 and in particular to compositions and methods for therapeutic use.
    Type: Application
    Filed: August 4, 2011
    Publication date: November 14, 2013
    Applicant: Conrig Pharma ApS
    Inventors: John Bondo Hansen, Mikael Søndergaard Thomsen